论文部分内容阅读
目的评估三氧联合人工肝支持系统治疗重型病毒性肝炎的临床价值。方法重型病毒性肝炎患者248例,采用随机方法分为对照组和治疗组。对照组给予保肝、促肝、调节免疫、防治并发症等支持对症治疗,治疗组在常规组治疗的基础上给予血浆置换治疗或三氧联合人工肝血浆置换治疗。结果治疗组与对照组治疗有效率分别为73.44%和46.67%,差异有统计学意义(χ2=4.15,P<0.05)。结论人工肝血浆置换是治疗重型病毒性肝炎的有效途径。
Objective To evaluate the clinical value of triple oxygen combined artificial liver support system in the treatment of severe viral hepatitis. Methods 248 patients with severe viral hepatitis were randomly divided into control group and treatment group. The control group was given symptomatic treatment of hepatoprotection, promoting liver, immune regulation and prevention and treatment of complications. The treatment group was treated with plasma exchange or triple oxygenation with artificial liver plasma exchange on the basis of routine treatment. Results The effective rates of the treatment group and the control group were 73.44% and 46.67%, respectively, with significant difference (χ2 = 4.15, P <0.05). Conclusion Artificial liver plasma exchange is an effective way to treat severe viral hepatitis.